Manchester scientists pave the way for greener cancer treatments

Discovery of new family of ligase enzymes could revolutionize the production of treatments for cancer

9 Jul 2024

Industry news

Scientists from the University of Manchester have uncovered a more efficient and sustainable way to make peptide-based medicines, showing promising effectiveness in combating cancers.

The Manchester scientists have discovered a new family of ligase enzymes – a type of molecular glue that can help assemble short peptide sequences more simply and robustly, yielding significantly higher quantities of peptides compared to conventional methods. This breakthrough could revolutionize the production of treatments for cancer and other serious illnesses, offering a more effective and environmentally friendly method of production.

The team searched for new ligase enzymes involved in the biological processes that assemble natural peptides in simple bacteria. They successfully isolated and characterized these ligases and tested them in reactions with a wide range of amino acid precursors. By analyzing the sequences of the bacterial ligase enzymes, the team identified many other clusters of ligases likely involved in other peptide pathways

The study provides a blueprint for how peptides, including important medicines, can be made in the future. Following the discovery, the team will now optimize the new ligase enzymes, to improve their output for larger scale peptide synthesis. They have also established collaborations with a number of the top pharmaceutical companies to help with rolling out the new ligase enzyme technologies for manufacturing future peptide therapeutics.

Professor Jason Micklefield, who led the team at The University of Manchester, said, “Using our new ligase enzymes we can produce peptides with promising anti-cancer activity in a single process with excellent yields. Previously, these types of peptides were produced in much lower yields, by a very laborious 10–12 step chemical synthesis process. By combining different ligases together in a single cascade reaction, we can make many different peptides.”

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>

Links

Tags

EnzymesEnzymes are macromolecular biological catalysts used across life science, pharmaceutical and clinical research. Various enzymes can be purchased for research applications including ligases, high fidelity polymerases, nuclease, protease, restriction enzymes, tissue dissociation enzymes and enzyme inhibitors. Find the best enzymes in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.TherapeuticsTherapeutics are treatments designed to alleviate or cure diseases. These include pharmaceuticals, biologics, and gene therapies, which work by targeting specific disease mechanisms. Advances in personalized medicine and biologics offer new hope for patients with conditions that were previously difficult to treat. Browse our peer-reviewed product directory to find therapeutic solutions for various diseases; compare products, check user reviews, and get pricing directly from manufacturers.PeptidesPeptides are short chains of amino acids that play key roles in biological processes, including signaling, immune responses, and enzyme regulation. Peptide research is critical in drug discovery, diagnostics, and vaccine development. Browse our peer-reviewed product directory to find the best peptides and peptide-related products, compare options, check reviews, and get pricing directly from manufacturers.SustainabilitySustainability in research and industry focuses on reducing environmental impact, conserving resources, and promoting long-term ecological balance. Innovations in sustainable practices include renewable energy, waste reduction, and eco-friendly materials. Explore more sustainabile solutions in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.Cancer Therapy